Yoo GH - Search Results

1

Risk stratification based on thyroid cytology: can we rely on national data?

Cohen DS, VandeGriend ZP, Yoo GH, Folbe AJ, Lin HS. Cohen DS, et al. Among authors: yoo gh. Am J Otolaryngol. 2014 May-Jun;35(3):362-5. doi: 10.1016/j.amjoto.2013.12.014. Epub 2014 Jan 2. Am J Otolaryngol. 2014. PMID: 24656510

2

Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: a case report and review of the literature.

Shehadeh NJ, Vernick J, Lonardo F, Madan SK, Jacobs JR, Yoo GH, Kim HE, Ensley JF. Shehadeh NJ, et al. Among authors: yoo gh. Am J Otolaryngol. 2004 Jan-Feb;25(1):48-53. doi: 10.1016/s0196-0709(03)00096-6. Am J Otolaryngol. 2004. PMID: 15011206 Review.

3

Prognostic significance of p53 and FHIT in advanced oropharyngeal carcinoma.

Otero-Garcia JE, Youssef E, Enamorado II, Du W, Yoo GH, Merati K, Kewson D, Lonardo F, Jacobs JR, Kim H. Otero-Garcia JE, et al. Among authors: yoo gh. Am J Otolaryngol. 2004 Jul-Aug;25(4):231-9. doi: 10.1016/j.amjoto.2004.01.001. Am J Otolaryngol. 2004. PMID: 15239028

4

Microsatellite alterations in african americans with head and neck cancer.

Yoo GH, Nguyen NX, Du W, Schwartz AG, Land S, Lin HS, Kewson D, Murphy LL, Cilluffo D, Ensley JF, Tainsky MA. Yoo GH, et al. Laryngoscope. 2004 Sep;114(9):1619-24. doi: 10.1097/00005537-200409000-00021. Laryngoscope. 2004. PMID: 15475792

5

Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer.

Yoo GH, Piechocki MP, Oliver J, Lonardo F, Zumstein L, Lin HS, Kim H, Shibuya TY, Shehadeh N, Ensley JF. Yoo GH, et al. Laryngoscope. 2004 Nov;114(11):1871-9. doi: 10.1097/01.mlg.0000147914.51239.ed. Laryngoscope. 2004. PMID: 15510008

6

Prognostic significance of G1 cell-cycle inhibitors in early laryngeal cancer.

Korkmaz H, Du W, Yoo GH, Enamorado II, Lin HS, Adsay V, Kewson D, Ensley JF, Shibuya TY, Jacobs JR, Kim H. Korkmaz H, et al. Among authors: yoo gh. Am J Otolaryngol. 2005 Mar-Apr;26(2):77-82. doi: 10.1016/j.amjoto.2004.08.001. Am J Otolaryngol. 2005. PMID: 15742257

7

An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma.

Yoo GH, Subramanian G, Boinpally RR, Iskander A, Shehadeh N, Oliver J, Ezzat W, Piechocki MP, Ensley JF, Lin HS, Shibuya TY, Polin L, Parchment RE. Yoo GH, et al. Arch Otolaryngol Head Neck Surg. 2005 May;131(5):418-29. doi: 10.1001/archotol.131.5.418. Arch Otolaryngol Head Neck Surg. 2005. PMID: 15897421

8

Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.

Yoo GH, Lin HS, Iskander AJ, Piechocki MP, Oliver J, Kewson D, Lonardo F, Tainsky MA, Kim HR, Kim H, Ensley JF. Yoo GH, et al. Laryngoscope. 2005 Nov;115(11):1938-46. doi: 10.1097/01.mlg.0000177456.90870.94. Laryngoscope. 2005. PMID: 16319602

9

Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck.

Shehadeh NJ, Ensley JF, Kucuk O, Black C, Yoo GH, Jacobs J, Lin HS, Heilbrun LK, Smith D, Kim H. Shehadeh NJ, et al. Among authors: yoo gh. Head Neck. 2006 Dec;28(12):1090-8. doi: 10.1002/hed.20470. Head Neck. 2006. PMID: 16933316

10

BMS-275183-induced gene expression patterns in head and neck carcinoma.

Yoo GH, Tran VR, Lemonnier LA, Ezzat WH, Subramanian G, Piechocki MP, Ensley JF, Lonardo F, Kim H, Lin HS. Yoo GH, et al. Am J Otolaryngol. 2007 Sep-Oct;28(5):309-15. doi: 10.1016/j.amjoto.2006.10.001. Am J Otolaryngol. 2007. PMID: 17826531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters